DGS Capital Management, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1900110 JERSEY CITY, NJ

Position in TEVA

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$329,663

-$7,061 QoQ

Shares Held

10,945

+1.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 42% Shared 0% None 58%

Healthcare · as of Mar 31, 2026

DGS Capital Management, LLC holds $2,551,701 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (12.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	52,937	$733,177
2	UTHR	UNITED THERAPEUTICS Corp	1,034	$613,141
3	TAK	Takeda Pharmaceutical Co Ltd	23,106	$427,923
4	TEVA	Teva Pharmaceutical Industries Ltd This page	10,945	$329,663
5	SIGA	Siga Technologies Inc	42,434	$227,021
6	VTRS	Viatris Inc	12,475	$168,537
7	IRWD	Ironwood Pharmaceuticals Inc	14,883	$52,239

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$329,663	10,945	+1.4%	Shares	Sole	2026-04-28
2025-12-31	$336,724	10,789	+0.5%	Shares	Sole	2026-02-24
2025-09-30	$216,887	10,737	-11.1%	Shares	Sole	2026-02-24
2025-06-30	$202,460	12,080	-12.0%	Shares	Sole	2026-02-24
2025-03-31	$211,030	13,730	-10.5%	Shares	Sole	2026-02-24
2024-12-31	$338,093	15,340	+12.6%	Shares	Sole	2025-01-21
2024-09-30	$245,558	13,627	+6.8%	Shares	Sole	2024-12-10
2024-06-30	$207,268	12,755	+10.1%	Shares	Sole	2024-12-10
2024-03-31	$163,393	11,580	+1.7%	Shares	Sole	2024-04-15
2023-12-31	$118,901	11,389	-18.9%	Shares	Sole	2024-01-30
2023-03-31	$124,315	14,047	-7.9%	Shares	Sole	2023-06-16
2022-12-31	$139,089	15,251	+39.6%	Shares	Sole	2023-02-21
2022-09-30	$88,156	10,924	-30.0%	Shares	Sole	2023-02-21
2022-03-31	$146,587	15,611	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.